Introduction & Objective: Nocturnal enuresis as a common disorder in children can create many problems. A variety of modalities has been used for its treatment but applying new and effective modalities can be of much interest.
P Yazdanpanah +5 more
doaj
Infant Nephrogenic Diabetes Insipidus: Challenges Leading to Delayed Management. [PDF]
Stankovic M S +10 more
europepmc +1 more source
Severe Transient Central Diabetes Insipidus After Pituitary Adenoma Removal With Peak Urine Output of 33.5 L in 24 h. [PDF]
Bhandari G +3 more
europepmc +1 more source
Tirzepatide-associated hyponatremia in a patient with known arginine vasopressin deficiency. [PDF]
Caputo C.
europepmc +1 more source
PO39 | Bleeding events in Von Willebrand disease type 1 yearly treatable with desmopressin
Background and Aims: Subcutaneous and intranasal desmopressin is safe and effective in type 1 VWD, and particularly convenient for pediatric use and home treatment.
doaj +1 more source
Glucocorticoid-induced arginine vasopressin deficiency and neurohypophyseal T1-hyperintensity transient switch-off. [PDF]
Marques P, Neto L, Fontes L, Sapinho I.
europepmc +1 more source
Bleeding prevention with desmopressin for allograft kidney biopsies: a double-blind randomized study. [PDF]
Pacini GS +9 more
europepmc +1 more source
Severe Diabetic Ketoacidosis With Refractory Hypernatremia due to Hypokalemia-Induced Arginine Vasopressin Resistance: A Case Report and Literature Review. [PDF]
Shihab R +4 more
europepmc +1 more source
Real-World Safety and Effectiveness of an Initial 0.1 mg Dose of Desmopressin in Older Men With Nocturnal Polyuria. [PDF]
Chu C, Lin CC.
europepmc +1 more source
Central Diabetes Insipidus Following Steroid Replacement for Hypoadrenalism in Pembrolizumab-Induced Hypophysitis. [PDF]
Alasmar A, San SS, Ta T, Mani SE.
europepmc +1 more source

